«The
vaccination approach we have employed is not prophylactic but therapeutic, meaning that immunity was induced
after the onset of tumorigenesis — a scenario that resembles the clinical conditions much more
closely than prophylactic immunization studies, says Anna - Karin Olsson, researcher at the Department of Medical Biochemistry and Microbiology at Uppsala University,» who has led the study.